Lithium, ACE inhibitors, NSAIDs, and verapamil. A possible fatal combination

Psychosomatics

Volumn 39, Issue 3, 1998, Pages 281-282

  Chandragiri, Sanjay S ^a   Pasol, Elias ^a   Gallagher, Rollin M ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DATA ANALYSIS; DRUG MIXTURE; FATALITY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SODIUM DEPLETION; URINARY EXCRETION;

EID: 0031800048     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(98)71345-3     Document Type: Letter

References (9)

1. Finley RP: Drug interactions with lithium. Clin Pharmacokinet 1995; 29:172-191
2. Das Gupta K, Jefferson JW, Kobak KA, et al: The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry 1992; 53:398-400
3. Finley PR, O'Brien JG, Coleman RW: Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol 1996; 16:68-71
4. Brunner HR, Waeber B, Nussberger J: Renal effects of converting enzyme inhibition. J Cardiovasc Pharmacol 1987; 9(suppl 3):6-14
5. Mason NA: Angiotensin-converting enzyme inhibitors and renal function. DICP 1990; 24:496-505
6. Johnson AG, Seideman P, Day RO: Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs): recognition, management and avoidance. Drug Saf 1993; 8:99-127
7. Shionoiri H: Pharmacokinetic drug interactions with ACE inhibitors. Clin Pharmacokinet 1993; 25:20-58
8. Dubovsky Sl, Franks RD, Allen S: Verapamil: a new antimanic drug with potential interactions with lithium. J Clin Psychiatry 1987; 48:371-372
9. Price WA, Giannini AJ: Neurotoxicity caused by lithium-verapamil synergism. J Clin Pharmacol 1986; 26:717-719